Advancing Prostate Cancer Diagnostics: The Potential of Paper-Based Biosensors for Point-of-Care Testing

Key Points

• Biosensors showed enhanced sensitivity for detecting prostate cancer biomarkers, leading to potentially quicker diagnoses.
• A key finding was the increased specificity of these paper-based tests in distinguishing cancerous from non-cancerous samples.
• Analysis of biosensors reveals their effectiveness in point-of-care testing settings, which can streamline patient evaluation.
• Using paper-based biosensors could enable efficient and accessible prostate cancer diagnostics; further validation is needed.